Why meQuilibrium?

meQuilibrium is a digital coaching platform that delivers clinically validated and highly personalized resilience solutions to employers, health plans, wellness providers, and consumers increasing engagement, productivity, and performance and improving outcomes in managing stress, health, and well-being.

meQuilibrium is a scalable software-as-a-service (SaaS) platform that helps users build resilience, beat stress, and adopt healthy behavior for life. The clinically validated, HIPAA compliant platform, delivers an individualized digital coaching experience via the web and mobile devices.

meQuilibrium services two key markets: large enterprise companies, eager to stem the estimated $300 billion they lose each year in employee absenteeism and lost productivity due to stress, and health plans seeking to drive differentiation and innovation in an era of consumer-driven healthcare. meQuilibrium also serves individuals looking to improve the quality of their lives.

meQuilibrium offers every user a confidential, individualized experience, created just for them. Users are guided through a journey that begins with a personalized assessment, followed by a long-term roadmap, which focuses on boosting critical skills to build resilience. In turn, intelligence from the aggregated meQuilibrium users fuels a new generation of helpful metrics and insights for the C-suite with snapshots on workforce well-being that can inform strategies and decision-making.

meQuilibrium’s digital program is based on the clinically validated research of Chief Science Officer and Brookings Institute Fellow Dr. Andrew Shatté, and Chief Medical Officer Dr. Adam Perlman, Executive Director of Integrative Medicine and Wellness at Duke University, and incorporates the latest thinking in positive psychology and integrative medicine.

Market Opportunity

In the latest Staying@Work Survey from Towers Watson, employers from around the world emphasize that stress is the #1 lifestyle risk factor, propelling absenteeism, productivity, injury and turnover costs. These factors cost U.S. businesses an estimated $300 billion annually, and healthcare expenditures are estimated to be 50% greater for high-stress workers.

Company Milestones

  • New Life Solution, Inc., d/b/a meQuilibrium, publishes “meQuilibrium: 14 Days to Cooler, Calmer, and Happier”
  • meQuilibrium expands team with Kevin Howat as Senior Vice President, Healthcare and Channel Sales
  • meQuilibrium expands team with Molly Doyle as Chief Product Officer
  • meQuilibrium expands team with Scott Fillenworth as Executive Vice President, Sales and Business Development
  • meQuilibrium launches enhanced mindfulness meditation offering